Metagenomic and metabolomic profiling in primary aldosteronism with coexisting obstructive sleep apnea

• by Li Yang, Yi Tao, Yan He, Shijie Liu, Lulu Gan, Anni Dai, Qing Ni, Yun Wang, Fengping Li, Qian Liu, Yang Hu, Yanqi Wang, Wugan Lu

• July 20, 2026

Higher Steroid Exposure Linked to Systemic Adverse Events in CRSwNP

Higher annual oral corticosteroid exposure was associated with greater odds of systemic adverse events, with avascular bone necrosis and pneumonia showing dose-dependent associations with cumulative dose and osteoporosis associated with longer annual exposure duration.

• by Andrea Surnit

• June 26, 2026

• 5 min

Dietary Inflammatory Potential and Cardiometabolic Risk Factors in School-Aged Adolescents

• by Luana de Oliveira Leite, Mônica Leila Portela de Santana, Nadjane Ferreira Damascena, Jacqueline Costa Dias Pitangueira, Priscila Ribas de Farias Costa

• July 1, 2026

FDA Approves First Therapy to Reduce Pancreatitis Risk

In two placebo-controlled trials, triglyceride levels declined by up to 72% compared with placebo.

• by Kathryn Wighton

• June 24, 2026

• 2 min